Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL - Abramson, JS; Gordon, LI; Palomba, ML (J Clin Oncol, 2018)
Im Internet